基于“清浊升降”理论探讨慢性阻塞性肺疾病的气机失常与辨治思路
Discussion on the Disorder of Qi Movement and the Approach to Syndrome Differentiation and Treatment of Chronic Obstructive Pulmonary Disease Based on the Theory of “Ascending of Clear and Descending of Turbid”
摘要: 本文以《黄帝内经》“清气在下,则生飧泄;浊气在上,则生䐜胀”的气机升降理论为切入点,系统探讨慢性阻塞性肺疾病(COPD)的中医病机本质与辨治策略。首先阐述该理论的核心内涵及其与COPD“肺失宣降、痰瘀互结”病机的内在联系。进而,从“肺脾相关”与“肠–肺轴”紊乱、“浊气在上”与气道慢性炎症及黏液高分泌、“清气不升”与全身性消耗及认知障碍、气机逆乱与COPD急性加重,以及基于气机升降理论的辨证分型与治则等五个方面,深入剖析COPD发生发展中气机升降失常的多维表现与病理环节。最后,总结以调畅气机为核心的整合治疗思路,为COPD的临床管理提供理论依据和实践参考。
Abstract: Based on the theory of ascending and descending of qi movement from the Huangdi Neijing, which states that “when clear qi stays below, it causes undigested food in diarrhea; when turbid qi stays above, it causes abdominal distension and fullness”, this paper systematically explores the pathogenesis and treatment strategies of chronic obstructive pulmonary disease (COPD) in traditional Chinese medicine. First, it elaborates the core connotation of this theory and its intrinsic relationship with the pathogenesis of COPD characterized by “loss of lung’s dispersing and descending functions and intermingling of phlegm and blood stasis”. Then, from five aspects—“lung-spleen relationship” and “gut-lung axis” dysregulation, “turbid qi upward disturbance” and airway chronic inflammation and mucus hypersecretion, “clear qi failing to ascend” and systemic wasting and cognitive impairment, reversal and disorder of qi movement and acute exacerbation of COPD, as well as syndrome differentiation and treatment principles based on the theory of ascending and descending of qi movement—it deeply analyzes the multidimensional manifestations and pathological links of disordered qi ascending and descending during the development of COPD. Finally, it summarizes an integrated treatment approach centered on regulating and smoothing qi movement, providing a theoretical basis and practical reference for the clinical management of COPD.
文章引用:陶友用, 卓铭松, 张梁亮, 许光兰. 基于“清浊升降”理论探讨慢性阻塞性肺疾病的气机失常与辨治思路[J]. 中医学, 2026, 15(6): 92-99. https://doi.org/10.12677/tcm.2026.156317

参考文献

[1] Fortis, S., Georgopoulos, D., Tzanakis, N., Sciurba, F., Zabner, J. and Comellas, A.P. (2024) Chronic Obstructive Pulmonary Disease (COPD) and COPD-Like Phenotypes. Frontiers in Medicine, 11, Article ID: 1375457. [Google Scholar] [CrossRef] [PubMed]
[2] 张元兵, 章程, 胡志平, 等. 国医大师洪广祥教授应用气机升降理论辨治肺系病症思想探讨[J]. 中华中医药杂志, 2018, 33(11): 4964-4967.
[3] 许博文, 陈珂, 童佳兵, 等. 国医大师韩明向基于“气一元论”的慢性阻塞性肺疾病三阶段治疗体系探索[J]. 中国中医药信息杂志, 2025, 32(10): 160-163.
[4] 钱丽燕. 蔡宛如教授从“脏腑之气”分治慢性阻塞性肺疾病[J]. 浙江中医药大学学报, 2019, 43(6): 571-573.
[5] Chen, Y., Li, P., Wang, J., Wu, W. and Liu, X. (2022) Assessments and Targeted Rehabilitation Therapies for Diaphragmatic Dysfunction in Patients with Chronic Obstructive Pulmonary Disease: A Narrative Review. International Journal of Chronic Obstructive Pulmonary Disease, 17, 457-473. [Google Scholar] [CrossRef] [PubMed]
[6] Wang, J., Li, Y., Zhao, P., Tian, Y., Liu, X., He, H., et al. (2020) Exposure to Air Pollution Exacerbates Inflammation in Rats with Preexisting COPD. Mediators of Inflammation, 2020, Article ID: 4260204. [Google Scholar] [CrossRef] [PubMed]
[7] 尹红斌, 苏和. 苏和教授运用调理气机升降法治疗慢阻肺经验[J]. 当代医药论丛, 2024, 22(34): 116-118.
[8] 郭凤敏, 姚红艳. 慢性阻塞性肺疾病气机理论探讨[J]. 湖南中医杂志, 2015, 31(3): 131-132.
[9] 姜云宁, 王琦, 滕俊, 等. 从调畅三焦气机论治慢性阻塞性肺疾病[J]. 长春中医药大学学报, 2021, 37(2): 251-254.
[10] 龚钤升, 刘炜. 基于中医“从肝治痰”论治慢性阻塞性肺疾病气道黏液高分泌[J]. 中医临床研究, 2024, 16(29): 135-139.
[11] Wu, W., Li, Z., Wang, Y., Huang, C., Zhang, T. and Zhao, H. (2023) Advances in Metabolomics of Chronic Obstructive Pulmonary Disease. Chinese Medical Journal Pulmonary and Critical Care Medicine, 1, 223-230. [Google Scholar] [CrossRef] [PubMed]
[12] 黄新锋, 刘馨羽, 赵珊, 等. 基于“一气周流”理论探析慢性阻塞性肺病辨治阐微[J]. 长春中医药大学学报, 2025, 41(8): 830-834.
[13] 陈文畅, 陈乙菲, 李风森. 培土生金法治疗慢性阻塞性肺疾病的研究进展[J]. 世界中医药, 2024, 19(1): 133-138.
[14] 贺晓芳, 夏慧静, 马艳萍, 等. 基于肺脾“五行相生”理论探讨慢性阻塞性肺疾病与肌少症的关系[J]. 亚太传统医药, 2025, 21(9): 211-215.
[15] 刘虎, 刘云, 梁静. 刘云教授治疗慢性阻塞性肺疾病合并功能性便秘的临床经验[J]. 中国民族民间医药, 2025, 34(10): 93-97.
[16] 胡金亮, 李素云, 张兴红, 等. 基于复杂网络AECOPD证候分布及中药组合研究[J]. 世界科学技术-中医药现代化, 2015(6): 1268-1273.
[17] Jo, Y.S. (2022) Long-Term Outcome of Chronic Obstructive Pulmonary Disease: A Review. Tuberculosis and Respiratory Diseases, 85, 289-301. [Google Scholar] [CrossRef] [PubMed]
[18] 袁嘉丽, 李庆生. 慢支急发期痰热壅肺证、痰浊阻肺证患者的呼吸道微生态研究[J]. 上海中医药杂志, 2004, 38(5): 13-14.
[19] 董杨. 宽胸理肺汤治疗痰浊壅肺型慢性阻塞性肺病急性加重期临床研究[J]. 世界复合医学, 2019, 5(4): 136-138.
[20] 陈迅. 二陈汤合三子养亲汤治疗慢阻肺急性加重期(痰浊壅肺证)的临床疗效[J]. 北方药学, 2019, 16(8): 47-48.
[21] Wang, X., Hao, Y., Yin, Y., Hou, Y., Han, N., Liu, Y., et al. (2024) Lianhua Qingke Preserves Mucociliary Clearance in Rat with Acute Exacerbation of Chronic Obstructive Pulmonary Disease by Maintaining Ciliated Cells Proportion and Protecting Structural Integrity and Beat Function of Cilia. International Journal of Chronic Obstructive Pulmonary Disease, 19, 403-418. [Google Scholar] [CrossRef] [PubMed]
[22] Wu, Y., Di, X., Zhao, M., Li, H., Bai, L. and Wang, K. (2022) The Role of the NLRP3 Inflammasome in Chronic Inflammation in Asthma and Chronic Obstructive Pulmonary Disease. Immunity, Inflammation and Disease, 10, e750. [Google Scholar] [CrossRef] [PubMed]
[23] Shi, M., Liu, K., Li, X., Zeng, X. and Liu, X. (2025) Melatonin Ameliorates PM2.5-Induced Airway Inflammation and Apoptosis by PERK/eIF2α/ATF4/CHOP in Chronic Obstructive Pulmonary Disease Mice. Toxicology and Applied Pharmacology, 499, Article ID: 117314. [Google Scholar] [CrossRef] [PubMed]
[24] Kaluźniak-Szymanowska, A., Krzymińska-Siemaszko, R., Deskur-Śmielecka, E., Lewandowicz, M., Kaczmarek, B. and Wieczorowska-Tobis, K. (2021) Malnutrition, Sarcopenia, and Malnutrition-Sarcopenia Syndrome in Older Adults with COPD. Nutrients, 14, Article No. 44. [Google Scholar] [CrossRef] [PubMed]
[25] Murakami, T., Kobayashi, T., Ono, H., Shibuma, H., Tsuji, K., Nikkuni, E., et al. (2024) Phase Angle as an Indicator of Sarcopenia and Malnutrition in Patients with Chronic Obstructive Pulmonary Disease. Respiratory Investigation, 62, 651-656. [Google Scholar] [CrossRef] [PubMed]
[26] Tomita, M., Matsuse, H., Hashida, R., Murotani, K., Uchida, M., Monji, M., et al. (2024) Impact of Energy Malnutrition on Exacerbation Hospitalization in Patients with Chronic Obstructive Pulmonary Disease: Retrospective Observational Study. Journal of Nutritional Science and Vitaminology, 70, 44-52. [Google Scholar] [CrossRef] [PubMed]
[27] Park, S.H., Oh, J., Jo, M., Kim, J.K., Kim, D.S., Kim, H.G., et al. (2020) Water Extract of Lotus Leaf Alleviates Dexamethasone-Induced Muscle Atrophy via Regulating Protein Metabolism-Related Pathways in Mice. Molecules, 25, Article No. 4592. [Google Scholar] [CrossRef] [PubMed]
[28] Huang, W. and Ko, C. (2024) Systematic Review and Meta-Analysis of Nutrient Supplements for Treating Sarcopenia in People with Chronic Obstructive Pulmonary Disease. Aging Clinical and Experimental Research, 36, Article No. 69. [Google Scholar] [CrossRef] [PubMed]
[29] Naas, S., Fekete, M., Szendro, G., Komaromi, T., Rozgonyi, Z., Palmer, E., et al. (2026) Multimodal Therapeutic Strategies for the Management of Sarcopenia and Frailty in Chronic Obstructive Pulmonary Disease: A Narrative Review. Nutrients, 18, Article No. 543. [Google Scholar] [CrossRef
[30] Mao, X., Li, Y., Shi, P., Zhu, Z., Sun, J., Xue, Y., et al. (2023) Analysis of Sputum Microbial Flora in Chronic Obstructive Pulmonary Disease Patients with Different Phenotypes during Acute Exacerbations. Microbial Pathogenesis, 184, Article ID: 106335. [Google Scholar] [CrossRef] [PubMed]